Supplementary Data from Discovery of STRO-002, a Novel Homogeneous ADC Targeting Folate Receptor Alpha, for the Treatment of Ovarian and Endometrial Cancers

Xiaofan Li, Sihong Zhou, Cristina L. Abrahams, Stellanie Krimm, Jennifer Smith, Krishna Bajjuri, Heather Stephenson, Robert Henningsen, Jeffrey Hanson, Tyler H. Heibeck, Daniel Calarese, Cuong Tran, Gang Yin, Ryan Stafford, Alice Yam, Toni Kline, Venita I. De Almeida, Aaron K. Sato, Mark Lupher, Kristin Bedard, Trevor J. Hallam
In: American Association for Cancer Research · 2023 · doi:10.1158/1535-7163.22523104.v1 · W4362486298
preprint OA: gold CC0
🔓 Open OA copy View on OpenAlex View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-09 ⓘ

This paper presents supplementary data from the discovery of STRO-002, a homogeneous antibody-drug conjugate (ADC) targeting folate receptor alpha, for treating ovarian and endometrial cancers.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

supplementary text and figures

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK